Αρχειοθήκη ιστολογίου

Παρασκευή 8 Σεπτεμβρίου 2017

Annexin A2 contributes to cisplatin resistance by activation of JNK-p53 pathway in non-small cell lung cancer cells

Development of resistance to therapy continues to be a serious clinical problem in lung cancer management. We previously identified that Annexin A2 is significantly up-regulated in cisplatin-resistant non-smal...

from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2xknSYb

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου